Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-04-21
1999-06-15
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
544162, 546229, A61K 5104, C07D26530, C07D21126
Patent
active
059119705
ABSTRACT:
The present invention relates to a class of compounds having affinity for certain cancer cells, e.g. lung carcinomas, colon carcinomas, renal carcinomas, prostate carcinomas, breast carcinomas, malignant melanomas, gliomas, neuroblastomas and pheochromocytomas. The compounds of the present invention can also bind with high specificity to cell surface sigma receptors and can therefore be used for diagnostic imaging of any tissue having an abundance of cells with sigma receptors. The present invention provides such compounds as agents for diagnostic imaging and for detecting and treating tumors containing the cancer cells described above.
REFERENCES:
patent: 3591634 (1971-07-01), Thominet
patent: 3891671 (1975-06-01), Thominet
patent: 4279887 (1981-07-01), Baldwin et al.
patent: 4360511 (1982-11-01), Baldwin et al.
patent: 4430319 (1984-02-01), Blau et al.
patent: 4584187 (1986-04-01), Wieland et al.
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4647446 (1987-03-01), Sargent, III et al.
patent: 4673686 (1987-06-01), Thominet et al.
patent: 4888353 (1989-12-01), Lednicer et al.
patent: 4937260 (1990-06-01), DePaulis et al.
patent: 5122361 (1992-06-01), Kung et al.
patent: 5154913 (1992-10-01), DePaulis et al.
patent: 5190741 (1993-03-01), Moreau et al.
patent: 5213787 (1993-05-01), Wilbur et al.
patent: 5349063 (1994-09-01), Joshua et al.
John et al. (1992) J. Nuc. Med. 33:889-890, Abstract #274.
John et a.. (1992) Abstr. Pap. Am. Chem. Soc. 204(1-2) .MEDI131.
Raymond A. Murphy, et al., "Synthesis and Characterization of Iodobenzamide Analogues:Potential D-2 Dopamine REceptor Imaging Agents", J. Med. Chem., 1990, 33:171-178.
Mei-Ping Kung, et al.; "The Characterization of IBF as a New Selective Dopamine D-2 Receptor Imaging Agent", J. Nuc. Med., 1990, 31:648-654. IBZM as a D2-dopamine receptor antagonist in Parkinson's disease", European Journal of Radiology: 12 (1991) :182-186.
Michelot, et al. (1991), J. Nucl. Med. 32: 1573-1580.
Meyniel, et al. (1990), C.R. Acad. Sci. Paris, t3ll, Serie III, 13-18.
C.S. John, et al., (1993), " A malignant Melanoma, Imaging Agent: Synthesis, Characterization, In Vitro Binding & Diodistribution of Iodind-125-(2-Piperidiny-laminoethyl)4-Iodobenzamide," J. Nuc. Med. 34: pp. 2169-2175.
Wojciech T. Bem, et al., (1991), "Overexpression of .sigma. Receptors in Nonneural Human Tumors," Cancer Research, 51: pp. 6558-6562.
Xuao-shu He, et al., (1993), "Synthesis and Binding Characteristics of Potential SPECT Imaging Agents for .sigma.-1 and .sigma.-2 Binding Sites," J. Med. Chem. 36: pp. 566-571.
Brian R. de Costa, et al., (1992), "Synthesis Characterization, and Biological Evaluation of a Novel Class of N-(Arylethyl)-N-alkyl-2-1(1-pyrrolidinyl) ethylamines:Structural Requirements and Binding Affinity at the .sigma. Receptor," J. Med Chem. 35:38-47.
Christy S. John, et al., (1994), "Synthesis and Characterization of . . . ," J. MEd. Chem. 37: pp. 1737-1739.
Bertold J. Vilner, et al., (1995), "Sigma-2 Receptors Are Expressed in a Wide Variety of Human and Rodent Tumor Cell Lines," Cancer Research 55: pp. 408-413.
Brian R. de Costa, et al., (1993), "Synthesis and Evaluation of Conformationally Restricted . . . ," J. Med. Chem. 36: pp.2311-2320.
S.M.N. Efange, et al., (1993), "Synthesis and Biological Evaluation of Radioiodinated N-2-94 . . . ," Nucl. Med. Biol. vol. 20: pp. 527-538. Med. Biol. vol. 20, No. 1, pp. 75-79.
T.W. Moody et al(1994), Proceedings of the American Assoc, For Cancer Research vol. 35: p. 266.
Ingrid Pettersson, et al., (1992), "Conformation Analysis of Dopamine D-2 Receptor Antagonists of the Benzamine Series in Relation to a Recently Proposed D-23 . . . ," J. Med. Chem. 35: pp. 23-55-2363.
Deborah Kotz, (1995), "Scintimammography: Magic Bullet or False Promise?", The Journal of Nuclear Medicine vol. 36: pp. 15N-19N.
Lamk M. Lamki, (1995), Tissue Characterizationin Nuclear Oncology: Its time has come,: The Journal of Nuclear Mecicine vol. 36: pp. 207-210.
John L. Arachibald, et al., (1994), "Benzamidioperidines. 3. Carbocylic Derivatives Related to Indoramin," J. Med. Chem. vol. 17: pp. 739-747.
Bertold J. Vilner, et al., (1994), "Cytotoxic Effects of Sigma Ligands: Sigma Receptor-mediated Alterations in Cellular Morphology and Viability,", Neuroscience Gal. 82-90.
Christy S. John, et al., (1995), "Synthesis and Pharmacological Characterization . . . ,", Cancer Research 55: pp. 3022-3027.
Christy S. John, et al. (1995), "Sigma Receptors Are Expressed in Human Non-Small Cell Lung Carcinoma,", Life Sciences, vol. 56, No. 26, pp. 2385-2392.
Christy S. John, et al., (1995), "Synthesis, Binding Characteristics and In-Vivo Clearance of . . . ,", J. Med. Chem. p. 6. (abstract book). and . . . ,", J. Med. Chem. 36: p. 124. (abstract book).
Christy S. John, et al., (1995), "Characterization of Sigma Receptors of Neural Tumor Cells Using Radioiodinated Benazmides,", J. Med. Chem. 36: p. 144 (abstract book).
Christy S. John, et al., (1995), "Synthesis and Character of (N-Benzylpiperidin-4 YL-4 . . . ,", J. Med. Chem. 35: p. 246 (abstract book).
Christy S. John, et al., (1995), "Sigma Receptors are Expressed in Non-small Cell Lung Carcinoma; Potential Use For Tumor Visualization,", J. Med. Chem. 35: p. 248.
Christy S. John et al., "Targeting Sigma Receptor Specific Radiopharmaceuticals at Human Malignant Breast Lung and Melanoma Cells for Early Detection of Cancer" (1994), GWUMC 1st Annual GW Health Sciences Research Day, Abstract 151.
J. Prieto, et al., "Synthesis and Pharmacological Properties of a Series of Antidopaminergic Piperidyl Benzamides", 1977, J. Pharm. Pharmac. 29:147-152.
Alan R. Fritzberg, et al., "Approaches to Radiolabeling of Antibodies for Diagnosis and Therapy of Cancer", 1988, Pharm. Res. 5(6):324-334.
Solomons, Organic Chemistry, 1988, p. 899, Print Without Publication Month.
Baumgold Jesse
Bowen Wayne
John Christy S.
McAfee John G.
Moody Terry
Dees Jos,e G.
Hartley Michael G.
Research Corporation Technologies Inc.
LandOfFree
Methods for cancer imaging and therapy using benzamine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for cancer imaging and therapy using benzamine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for cancer imaging and therapy using benzamine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-400832